The ongoing fight against HIV is hindered by the lack of an effective vaccine and the virus's ability to develop drug resistance, highlighting the need for new therapies.
This study utilized a deep-learning method called a long short-term memory (LSTM) variational autoencoder to explore potential new drugs for HIV, training on a dataset of 1,377 SMILES-encoded compounds with a high accuracy of 91%.
The research generated new drug candidates, evaluated their interactions with HIV using AI models, and confirmed their drug likeliness based on Lipinski's rule of five, showcasing a promising direction for drug discovery against HIV.